Eversept Partners LP Sells 16,645 Shares of HCA Healthcare, Inc. $HCA

Eversept Partners LP decreased its position in HCA Healthcare, Inc. (NYSE:HCA) by 17.4% in the 1st quarter, HoldingsChannel reports. The institutional investor owned 79,229 shares of the company’s stock after selling 16,645 shares during the period. HCA Healthcare accounts for 2.0% of Eversept Partners LP’s holdings, making the stock its 13th biggest position. Eversept Partners LP’s holdings in HCA Healthcare were worth $37,494,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently modified their holdings of the business. Palisade Asset Management LLC bought a new stake in HCA Healthcare during the third quarter worth $26,000. Ares Financial Consulting LLC purchased a new stake in shares of HCA Healthcare during the 4th quarter valued at $31,000. Cedar Mountain Advisors LLC purchased a new position in shares of HCA Healthcare in the 1st quarter worth about $33,000. MCF Advisors LLC increased its holdings in HCA Healthcare by 213.0% during the fourth quarter. MCF Advisors LLC now owns 72 shares of the company’s stock worth $34,000 after buying an additional 49 shares during the last quarter. Finally, Basepoint Wealth LLC purchased a new position in HCA Healthcare in the fourth quarter valued at about $35,000. 62.73% of the stock is owned by hedge funds and other institutional investors.

Key HCA Healthcare News

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: Q2 results exceeded expectations. HCA reported adjusted earnings of $7.59 per share versus the $7.56 consensus estimate, while revenue rose 8.7% year over year to $20.23 billion, topping forecasts of $19.76 billion. The earnings beat and continued revenue growth are supporting investor sentiment. HCA Healthcare’s Q2 CY2026 sales top estimates
• Positive Sentiment: Analysts remain broadly constructive despite lower targets. Truist, Oppenheimer and KeyCorp cut their price targets but retained buy, outperform or overweight ratings. RBC also reaffirmed its outperform rating with a $435 target, indicating that analysts still see upside from current levels. HCA Healthcare Analysts Slash Their Forecasts After Q2 Results
• Neutral Sentiment: HCA declared a quarterly dividend of $0.78 per share. The dividend is payable September 30 to shareholders of record September 16 and carries an indicated yield of approximately 0.8%, providing modest shareholder income.
• Neutral Sentiment: Leadership change at two Tampa hospitals. HCA promoted a new chief executive officer for the facilities, a routine management update with limited immediate financial impact. HCA promotes new CEO of 2 Tampa hospitals
• Negative Sentiment: Uninsured Affordable Care Act patients are a concern. Nearly all of HCA’s ACA exchange patients reportedly lacked insurance coverage during the quarter, highlighting reimbursement and bad-debt risks that could weigh on margins and future earnings.
• Negative Sentiment: Multiple analysts reduced their forecasts after the earnings release. Barclays moved to equal weight with a $387 target, while Baird maintained a neutral rating and lowered its target to $393. The widespread target reductions suggest expectations for HCA’s future growth and profitability have moderated.
• Negative Sentiment: Mission Health compliance concerns remain unresolved. Reports of a third consecutive year of compliance issues add legal, regulatory and reputational risk for HCA. HCA Healthcare faces third straight year of Mission Health compliance concerns

HCA Healthcare Stock Performance

Shares of HCA opened at $389.74 on Tuesday. The stock has a market capitalization of $86.46 billion, a price-to-earnings ratio of 13.05, a price-to-earnings-growth ratio of 1.29 and a beta of 1.12. HCA Healthcare, Inc. has a 52-week low of $331.61 and a 52-week high of $556.52. The stock’s 50-day simple moving average is $386.30 and its 200 day simple moving average is $452.90.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Friday, July 24th. The company reported $7.59 earnings per share for the quarter, beating the consensus estimate of $7.56 by $0.03. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%.The firm had revenue of $20.23 billion for the quarter, compared to analysts’ expectations of $19.76 billion. During the same period in the prior year, the business posted $6.84 earnings per share. The company’s revenue was up 8.7% on a year-over-year basis. On average, research analysts forecast that HCA Healthcare, Inc. will post 29.19 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, September 30th. Shareholders of record on Wednesday, September 16th will be issued a $0.78 dividend. This represents a $3.12 annualized dividend and a yield of 0.8%. The ex-dividend date of this dividend is Wednesday, September 16th. HCA Healthcare’s dividend payout ratio (DPR) is presently 10.45%.

Analyst Upgrades and Downgrades

HCA has been the topic of several research analyst reports. KeyCorp dropped their price objective on HCA Healthcare from $475.00 to $435.00 and set an “overweight” rating on the stock in a research note on Monday. Oppenheimer lowered their target price on HCA Healthcare from $520.00 to $485.00 and set an “outperform” rating on the stock in a research note on Monday. Wells Fargo & Company set a $369.00 price objective on HCA Healthcare in a report on Monday, July 20th. JPMorgan Chase & Co. cut their target price on shares of HCA Healthcare from $535.00 to $490.00 and set a “neutral” rating for the company in a research report on Tuesday, May 19th. Finally, Sanford C. Bernstein reissued a “market perform” rating on shares of HCA Healthcare in a research report on Wednesday, July 15th. Fourteen research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, HCA Healthcare presently has a consensus rating of “Moderate Buy” and an average price target of $473.36.

HCA Healthcare Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.